#ProtonTherapy for #ProstateCancer? [Excerpt] Blue Cure Men's Health podcast with guest, Dr. Steven J. Frank MD, MD Anderson Cancer Center
About Dr. Steven J. Frank, MD
Steven J. Frank, MD, is an endowed tenured professor of Radiation Oncology and holds the Bessie McGoldrick Professorship in Clinical Research at The University of Texas MD Anderson Cancer Center. Dr. Frank is the Executive Director of the Particle Therapy Institute and Deputy Head of Strategy for the Division of Radiation Oncology. Dr. Frank’s lab is studying the biologic enhancement factor of proton therapy and FLASH radiotherapy for head and neck cancer. Dr. Frank has over 300 peer-reviewed publications, has authored many book chapters, and has recently published the first textbook on Proton Therapy based on the MD Anderson experience. Dr. Frank is amongst the first, if not the first, to use Intensity-Modulated Proton Therapy (IMPT) to treat head and neck tumors, and he is the Principal Investigator of an NIH/NCI-sponsored multi-institutional 440 patient Phase II/III randomized trial in advanced stage oropharyngeal cancer that compares outcomes after chemoradiation therapy with IMRT versus IMPT. Dr. Frank chairs the Head and Neck subcommittee for the Particle Therapy Cooperative Oncology Group, is a member of the Board and Executive Committee for the National Association of Proton Therapy, and is the past-chair of the head and neck oral boards examination for the American Board of Radiology. He has been funded by the NIH, the Prostate Cancer Foundation, the Texas Ignition Fund, Hitachi, Eli Lilly, C4 Imaging, and MD Anderson. Dr. Frank is a fellow of the American Brachytherapy Society, American College of Radiology, and a 2022 Fellow of the American Society of Radiation Oncology. Dr. Frank has also just been awarded the Henscke Award, the highest award bestowed by the American Brachy Society for his dedication, commitment and success in the brachy medical arena for all of North America. The awards ceremony was just held in Vancouver, CA.
About Gabe Canales
Gabe Canales has lived with low-risk prostate cancer since 2010, when he was diagnosed at age 35. He is the author of Unexpected Diagnosis: Prostate Cancer and the Wake-Up Call to Live Healthier and Happier, the founder of the nonprofit Blue Cure Foundation, and advocates for prostate cancer patients, and men's health issues.
About Blue Cure
Blue Cure is a 501c3 nonprofit organization, founded by Gabe Canales, who was diagnosed in 2010 with early-stage prostate cancer at age 35.
The Mission of Blue Cure is to save men from premature death, by empowering men with the knowledge that lifestyle choices can prevent and reduce the risk of leading causes of male death from lifestyle-driven chronic health conditions and cancers.
Blue Cure wants to end the stigma that keeps men from taking control of their health to live healthier, happier lives. BlueCure.org
#ProstateCancer #EndProstateCancer #EndCancer #Cancer #Oncology #MDAnderson #MensHealth #RadiationOncology #Urology #Prostate #GetChecked #Houston #CancerTreatment
